Email Alert Subscription
Step 1 of 3: Select Options
You may automatically receive Ligand Pharmaceuticals, Inc. financial information by email. Please enter your preferences for email notifications below and click "Continue"
to enter your contact information on the next page.
If you have already signed up and would like to review your subscription,
click here.
For printed material, please contact Erika Luib in Investor Relations at 858-550-7896.